Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000723492 | SCV000112447 | uncertain significance | not provided | 2014-07-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000225710 | SCV000168141 | benign | not specified | 2014-01-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
ARUP Laboratories, |
RCV000723492 | SCV001159590 | benign | not provided | 2022-04-27 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001826742 | SCV002093605 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2017-03-28 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004537357 | SCV004730710 | benign | DMD-related disorder | 2019-05-10 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |